Detalles de la búsqueda
1.
Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a).
J Biomol Struct Dyn
; 42(7): 3535-3562, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37216299
2.
3D QSAR pharmacophore based lead identification of G9a lysine methyltransferase towards epigenetic therapeutics.
J Biomol Struct Dyn
; 41(18): 8635-8653, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264111
3.
Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer's Agent.
ACS Med Chem Lett
; 14(11): 1531-1536, 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37974951
Resultados
1 -
3
de 3
1
Próxima >
>>